CD30 is a Marker of Activated Effector Regulatory T Cells in Solid Tumors Providing Clinical Rationale for the Combination of Brentuximab Vedotin and PD-1 Inhibitors
Cancer Research（2023）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined